NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has acquired Cytocell for an undisclosed sum.

Cytocell, based in Cambridge, UK, offers a portfolio of fluorescence in situ hybridization probes that can be used to detect gene arrangements related to inherted diseases and cancer. Oxford, UK-based OGT said that Cytocell's products complement its CytoSure cytogenetics array and next-generation sequencing products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Oct
17
Sponsored by
Lexogen

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.